N Kabashima Selected Research

Continuous Ambulatory Peritoneal Dialysis (CAPD)

5/2008	Falecalcitriol for conventional vitamin D therapy-resistant secondary hyperparathyroidism in a continuous ambulatory peritoneal dialysis patient.
2/2006	Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Kabashima Research Topics

Disease

2	Proteinuria 02/2010 - 11/2008
1	Hyperkalemia 02/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2010
1	Chronic Renal Insufficiency 02/2010
1	IGA Glomerulonephritis (IGA Nephropathy) 11/2008
1	Secondary Hyperparathyroidism 05/2008
1	Long QT Syndrome 02/2008
1	Peritoneal Fibrosis 02/2006
1	Hypertension (High Blood Pressure) 11/2001
1	Sclerosis 11/2001

Drug/Important Bio-Agent (IBA)

2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2006 - 11/2001
1	Angiotensin Receptor AntagonistsIBA 02/2010
1	Telmisartan (Micardis)FDA Link 02/2010
1	Proteins (Proteins, Gene)FDA Link 02/2010
1	mizoribineIBA 11/2008
1	26,26,26,27,27,27- hexafluoro- 1,25- dihydroxyvitamin D3IBA 05/2008
1	Vitamin D FDA LinkGeneric 05/2008
1	Ketoconazole (Nizoral)FDA LinkGeneric 02/2008
1	Ether (Diethyl Ether)IBA 02/2008
1	Glucose (Dextrose)FDA LinkGeneric 02/2006
1	Prednisolone (Predate)FDA LinkGeneric 02/2006
1	NF-kappa B (NF-kB)IBA 02/2006
1	GlucocorticoidsIBA 02/2006
1	Phosphotransferases (Kinase)IBA 11/2001

Therapy/Procedure

2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 05/2008 - 02/2006
1	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2010
1	Therapeutics 05/2008